References
- FengXChenAZhangYWangJShaoLWeiLApplication of dental nanomaterials: potential toxicity to the central nervous systemInt J Nanomedicine2015103547356525999717
- AlenazyMSMosadomiHAClinical implications of calcifying nanoparticles in dental diseases: a critical reviewInt J Nanomedicine20149273124376354
- ChengLZhangKWeirMDMeloMAZhouXXuHHNanotechnology strategies for antibacterial and remineralizing composites and adhesives to tackle dental cariesNanomedicine (Lond)201510462764125723095
- KuperNKOpdamNJBronkhorstEMHuysmansMCThe influence of approximal restoration extension on the development of secondary cariesJ Dent201240324124722226997
- BeduneauASaulnierPBenoitJPActive targeting of brain tumors using nanocarriersBiomaterials200728334947496717716726
- BlythBJFarhavarAGeeCValidation of serum markers for blood–brain barrier disruption in traumatic brain injuryJ Neurotrauma20092691497150719257803
- PaivaWSCorreiaADMarieSKNeuroinflammatory responses to traumatic brain injuryNeuropsychiatr Dis Treat20151177377625834452
- LouveauASmirnovIKeyesTJStructural and functional features of central nervous system lymphatic vesselsNature2015523756033734126030524
- U.S. Food and Drug Administration2015 Available from: http://www.fda.gov
References
- AryalMArvanitisCDAlexanderPMMcDannoldNUltrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous systemAdv Drug Deliv Rev2014729410924462453
- JainKKNanobiotechnology-based strategies for crossing the blood-brain barrierNanomedicine (Lond)2012781225123322931448
- FengXChenAZhangYWangJShaoLWeiLCentral nervous system toxicity of metallic nanoparticlesInt J Nanomedicine2015104321434026170667
- KreuterJDrug delivery to the central nervous system by polymeric nanoparticles: what do we know?Adv Drug Deliv Rev20147121423981489
- GeraetsLOomenAGKrystekPTissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in ratsPart Fibre Toxicol2014113024993397
- LouveauASmirnovIKeyesTJStructural and functional features of central nervous system lymphatic vesselsNature201561
- U.S. Food and Drug Administration2015 http://www.fda.gov
- BoverhofDRBramanteCMButalaJHComparative assessment of nanomaterial definitions and safety evaluation considerationsRegul Toxicol Pharmacol2015623